The road to elucidating the mechanism of manganese-bilirubin-induced cholestasis.
Goering
Peter L
PL
Center for Devices and Radiological Health, Food and Drug Administration, Rockville, Maryland 20852, USA. plg@cdrh.fda.gov
D000818:Animals; D001663:Bilirubin / Q000378:metabolism* / Q000494:pharmacology; D002780:Cholestasis, Intrahepatic / Q000139:chemically induced / Q000378:metabolism*; D002784:Cholesterol / Q000378:metabolism; D004195:Disease Models, Animal; D004347:Drug Interactions; D006801:Humans; D006903:Hydroxymethylglutaryl CoA Reductases / Q000378:metabolism; D008345:Manganese / Q000378:metabolism* / Q000494:pharmacology; D051381:Rats
D008345:Manganese; D002784:Cholesterol; D006903:Hydroxymethylglutaryl CoA Reductases; D001663:Bilirubin